Advances in treatment of bacterial meningitis

Bacterial meningitis kills or maims about a fifth of people with the disease. Early antibiotic treatment improves outcomes, but the effectiveness of widely available antibiotics is threatened by global emergence of multidrug-resistant bacteria. New antibiotics, such as fluoroquinolones, could have a...

Full description

Saved in:

Bibliographic Details
Published in:	The Lancet (British edition) Vol. 380; no. 9854; pp. 1693 - 1702
Main Authors:	van de Beek, Diederik, Brouwer, Matthijs C, Thwaites, Guy E, Tunkel, Allan R
Format:	Journal Article
Language:	English
Published:	Kidlington Elsevier Ltd 10.11.2012 Elsevier Elsevier Limited
Subjects:	acetaminophen Anti-Bacterial Agents - therapeutic use Antibiotics Bacteria Bacterial diseases Bacterial diseases of the nervous system. Bacterial myositis Biological and medical sciences burden of disease Community-Acquired Infections - drug therapy Community-Acquired Infections - epidemiology dexamethasone Disease Drug Therapy, Combination Epidemiology fluoroquinolones Forecasting General aspects Global Health glycerol Gram-Negative Bacterial Infections - drug therapy Gram-Positive Bacterial Infections - drug therapy Human bacterial diseases Humans Hypothermia Infectious diseases Internal Medicine Listeria Medical sciences Meningitis Meningitis, Bacterial - drug therapy Meningitis, Bacterial - epidemiology Mortality multiple drug resistance patients Penicillin Resistance people Recurrence Streptococcus infections Therapies, Investigational Treatment Outcome Infection Medicine Bacteriosis Nervous system diseases Bacterial meningitis Treatment
ISSN:	0140-6736, 1474-547X, 1474-547X
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!